These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 905570)

  • 1. Thromboxane A2: effects on airway and vascular smooth muscle.
    Svenssen J; Strandberg K; Tuvemo T; Hamberg M
    Prostaglandins; 1977 Sep; 14(3):425-36. PubMed ID: 905570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of the thromboxane-sensitive contractile systems of the rabbit aorta, dog saphenous vein and guinea-pig trachea.
    Jones RL; Peesapati V; Wilson NH
    Br J Pharmacol; 1982 Jul; 76(3):423-38. PubMed ID: 6286023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations.
    Coleman RA; Humphrey PP; Kennedy I; Levy GP; Lumley P
    Br J Pharmacol; 1981 Jul; 73(3):773-8. PubMed ID: 7248665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. U-46619, a selective thromboxane A2-like agonist? [proceedings].
    Coleman RA; Humphrey PP; Kennedy I; Levy GP; Lumley P
    Br J Pharmacol; 1980 Jan; 68(1):127P-128P. PubMed ID: 7357146
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM; Wu TS; Teng CM
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin endoperoxides and thromboxanes: role in platelets and in vascular and respiratory smooth muscle.
    Samuelsson B
    Acta Biol Med Ger; 1976; 35(8-9):1055-63. PubMed ID: 1007751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre- and post-junctional actions of prostaglandin I2, carbocyclic thromboxane A2 and leukotriene C4 in dog tracheal tissue.
    Inoue T; Ito Y
    Br J Pharmacol; 1985 Feb; 84(2):289-98. PubMed ID: 2983807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioassay of thromboxane A2 by contraction of guinea-pig lung parenchymal strip.
    Spławiński J; Wojtaszek B; Marcinkiewicz E
    Thromb Res; 1981 Jan 1-15; 21(1-2):35-44. PubMed ID: 6112804
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of prostaglandins and thromboxane A2 on the contractility of rabbit splenic capsular smooth muscle.
    Peskar BA; Förstermann U; Simmet T
    Artery; 1980; 8(1):1-6. PubMed ID: 7000038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological actions of SQ 29,548, a novel selective thromboxane antagonist.
    Ogletree ML; Harris DN; Greenberg R; Haslanger MF; Nakane M
    J Pharmacol Exp Ther; 1985 Aug; 234(2):435-41. PubMed ID: 3926986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 7-Oxabicyclo[2.2.1]heptane analogs as modulators of the thromboxane A2 and prostacyclin receptors.
    Sprague PW; Heikes JE; Harris DN; Greenberg R
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():337-43. PubMed ID: 6303073
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of the antagonist profile of SK&F 88046 on guinea pig trachea.
    Weichman BM; DeVan JF; Muccitelli RM; Tucker SS; Vickery LM; Wasserman MA
    Prostaglandins Leukot Med; 1984 Aug; 15(2):167-75. PubMed ID: 6593742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboxane A2-induced vascular endothelial cell damage and respiratory smooth muscle cell contraction: inhibition by flunarizine, a Ca2+-overload blocker.
    De Clerck F; Loots W; Somers Y; Van Gorp L; Verheyen A; Wouters L
    Arch Int Pharmacodyn Ther; 1985 Mar; 274(1):4-23. PubMed ID: 2990365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of endoperoxides and thromboxanes in anaphylactic reactions.
    Hamberg M; Svensson J; Hedqvist P; Strandberg K; Samuelsson B
    Adv Prostaglandin Thromboxane Res; 1976; 1():495-501. PubMed ID: 998440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
    Lardy C; Rousselot C; Chavernac G; Depin JC; Guerrier D
    Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological effects of 15-hydroperoxythromboxane A2 on platelets and aorta.
    Hammarström S
    Prostaglandins Med; 1980 May; 4(5):297-302. PubMed ID: 7403329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EP 171: a high affinity thromboxane A2-mimetic, the actions of which are slowly reversed by receptor blockade.
    Jones RL; Wilson NH; Lawrence RA
    Br J Pharmacol; 1989 Apr; 96(4):875-87. PubMed ID: 2743082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of trapidil on thromboxane A2-induced aggregation of platelets, ischemic changes in heart and biosynthesis of thromboxane A2.
    Ohnishi H; Kosuzume H; Hayashi Y; Yamaguchi K; Suzuki Y; Itoh R
    Prostaglandins Med; 1981 Mar; 6(3):269-81. PubMed ID: 6894333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human platelet thromboxane synthetase by 11a-carbathromboxane A2 analogs.
    Gorman RR; Maxey KM; Bundy GL
    Biochem Biophys Res Commun; 1981 May; 100(1):184-90. PubMed ID: 7196228
    [No Abstract]   [Full Text] [Related]  

  • 20. Thromboxane A2 biosynthesis in the ureter obstructed isolated perfused kidney of the rabbit.
    Morrison AR; Nishikawa K; Needleman P
    J Pharmacol Exp Ther; 1978 Apr; 205(1):1-8. PubMed ID: 633076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.